VanEck Vectors Pharmaceutical ETF (PPH): Price and Financial Metrics ETF
PPH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $86.54 | 52-week high | $99.51 |
| Prev. close | $86.94 | 52-week low | $79.95 |
| Day low | $85.97 | Volume | 193,400 |
| Day high | $87.24 | Avg. volume | 152,289 |
| 50-day MA | $90.32 | Dividend yield | 1.85% |
| 200-day MA | $91.59 |
PPH Stock Price Chart Interactive Chart >
VanEck Vectors Pharmaceutical ETF (PPH) ETF Bio
The investment objective of the Market Vectors Pharmaceutical ETF seeks to replicate as closely as possible the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index.
PPH ETF Info
| Issuer | Van Eck Associates |
| Expense Ratio | 0.36% |
| Underlying Index | MVIS US Listed Pharmaceutical 25 Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 639.53M |
| Net Asset Value (NAV) | $86.54 |
| Options? | Yes |
| Total Holdings | 27 |
PPH Top Holdings
| Symbol | Company | % of Total |
| LLY | Eli Lilly & Co | 11.99% |
| NVO | Novo Nordisk A/S | 7.93% |
| JNJ | Johnson & Johnson | 6.33% |
| ABBV | Abbvie Inc | 5.91% |
| BMY | Bristol-Myers Squibb Co | 5.81% |
| MCK | Mckesson Corp | 5.69% |
| MRK | Merck & Co Inc | 4.92% |
| COR | Cencora Inc | 4.81% |
| TEVA | Teva Pharmaceutical Industries Ltd | 4.7% |
| NVS | Novartis Ag | 4.68% |
PPH Price Returns
| 1-mo | -2.30% |
| 3-mo | -9.53% |
| 6-mo | -6.41% |
| 1-year | 9.08% |
| 3-year | 19.16% |
| 5-year | 46.47% |
| YTD | 7.87% |
| 2023 | 6.95% |
| 2022 | 2.64% |
| 2021 | 17.79% |
| 2020 | 5.48% |
| 2019 | 19.39% |
PPH Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||